Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jean Philippe Mouret"'
Autor:
Marc Lambert, C. Bassez, Stéphanie Deffarges, Valentine Verdier, Pierre Deharo, Thomas Cuisset, L. Fourcade, Jean Philippe Mouret, Thomas W Johnson, Jacques Quilici, Pierre-Emmanuel Morange, Marie-Christine Alessi, Jean Louis Bonnet, Guillaume Bonnet
Publikováno v:
European Heart Journal
European Heart Journal, Oxford University Press (OUP): Policy B, 2017, 38 (41), pp.3070-3078. ⟨10.1093/eurheartj/ehx175⟩
European Heart Journal, 2017, 38 (41), pp.3070-3078. ⟨10.1093/eurheartj/ehx175⟩
European Heart Journal, Oxford University Press (OUP): Policy B, 2017, 38 (41), pp.3070-3078. ⟨10.1093/eurheartj/ehx175⟩
European Heart Journal, 2017, 38 (41), pp.3070-3078. ⟨10.1093/eurheartj/ehx175⟩
Newer P2Y12 blockers (prasugrel and ticagrelor) demonstrated significant ischaemic benefit over clopidogrel after acute coronary syndrome (ACS). However, both drugs are associated with an increase in bleeding complications. The objective of the prese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16b54aa4f89e8565fb0ee95aaacb7e3c
https://pubmed.ncbi.nlm.nih.gov/31039217
https://pubmed.ncbi.nlm.nih.gov/31039217
Autor:
Sabrina Uhry, Jacques Quilici, Jean-Philippe Mouret, Jean Louis Bonnet, Pierre-Emmanuel Morange, Laurent Bali, Pierre-Julien Moro, Corinne Frere, Marc Lambert, Bénédicte Gaborit, Thomas Cuisset
Publikováno v:
Thrombosis Research. 124:33-36
Background Increased doses of antiplatelet therapy have been proposed to overcome the variability of response. However, the chronic dose of aspirin after DES remains controversial. Methods and results We assessed in a prospective and randomized study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e84ad24cf4419d9511c871f782005f8
https://doi.org/10.1016/j.thromres.2008.09.014
https://doi.org/10.1016/j.thromres.2008.09.014
Autor:
Jean-Philippe Mouret, Thomas Cuisset, Pierre-Julien Moro, Marie-Christine Alessi, Laurent Bali, Jean Louis Bonnet, Marc Lambert, Pierre-Emmanuel Morange, Jacques Quilici, Corinne Frere
Publikováno v:
JACC: Cardiovascular Interventions. 1(6):649-653
Objectives The aim of this study was to assess, in clopidogrel nonresponders undergoing elective percutaneous coronary intervention (PCI), the benefit of adjusted antiplatelet therapy with glycoprotein (GP) IIb/IIIa antagonist administration during P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7fc41b6f1fc224b11c88fa24dd61013
Autor:
Jean-Louis Bonnet, Thomas Cuisset, Christopher Mielot, Colette Monserrat, Jacques Quilici, Jean-Philippe Mouret, Roch Giorgi, Marc Lambert, Louis Carrega, Laurent Bali, Régis Guieu, Lyassine Nait-Saidi
Publikováno v:
Archives of Cardiovascular Diseases. 101(10):645-651
Objectif. - L'albumine modifiee par l'ischemie (IMA) est un biomarqueur diagnostique precoce de l'ischemie myocardique. Notre etude avait pour objectif d'evaluer la valeur pronostique de l'IMA chez les patients hospitalises pour syndrome coronaire ai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0143ce1d015f90e1434367a92dab0af
Autor:
Olivier Brissy, Jacques Quilici, Pierre-Julien Moro, Alain Barthélémy, Mathieu Coulange, Jean-Philippe Mouret, Jean-Louis Bonnet, Thomas Cuisset
Publikováno v:
Journal of Cardiology Cases. (1):e22-e25
Summary Background Pulmonary barotrauma is a rare but feared complication of scuba diving, with around 30% mortality. Objective We report an uncommon case of pulmonary barotrauma complicated by arterial gas embolism with both coronary and neurologica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2950173d173e9ccc5dfbd3ba8ba37d6d